Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)

NCT: NCT02984566 · ACTIVE_NOT_RECRUITING

NCT IDNCT02984566
StatusACTIVE_NOT_RECRUITING
Start Date2020-01-14
SponsorUniversity of Sydney (OTHER)
First posted
Last updated

Brief Summary

Primary and secondary liver cancer patients will receive liver SABR with or without KIM intervention.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑